TQF6422
Asset
Injectable therapeutic agent for overweight and obesity
- Stage
- Phase 1
- Modality
- Peptide
- Target
- Not known
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Obesity overweight
Phase 1, Not yet recruiting, NCT07794111, clinicaltrials.gov, Oct 31, 2026
In the full profile
- Owner and partners1
- Trials1
- Competitors8
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.